“These are bioweapons” ~ Karen Kingston
It turns out that these blood clots are different than the “rare” ones spoken about on the media that show up on CT scans and MRIs. These are microscopic and do not show up on tests, as they can only be detected using a blood test known as D-dimer.
Dr. Hoffe has been performing D-dimer tests on his mRNA “vaccinated” patients, which led him to discover that at least 62 percent of them have these microscopic blood clots.
“The most alarming part of this is that there are some parts of the body like the brain, spinal cord, heart and lungs which cannot [regenerate],” he says. “When those tissues are damaged by blood clots, they are permanently damaged.”
As a result, these patients have ‘Reduced Effort Tolerance’ (RET), which means that they have shortness of breath. In his video, Dr Hoffe explained that this is because the blood vessels in their lungs are now clogged up. This forces the heart to work harder to keep up against a greater resistance to get blood through to the lungs
This is known as pulmonary artery hypertension – high blood pressure in the lungs because blood cannot effectively get through. Those who have this condition often die of heart failure within a few short years.
The ambitions of the Wellcome Leap are made clear by the woman chosen to lead it, former director of the Pentagon’s DARPA, Regina Dugan. Dugan began her career at DARPA in 1986; she led a counterterrorism task force in 1999 before leaving DARPA a year later. […]
During her tenure, she created DARPA’s now defunct Transformational Convergence Technology Office, which focused on social networks, synthetic biology, and machine intelligence. Many of the themes previously managed by that office are now overseen by DARPA’s Bological Technologies Office, which was created in 2014 and focuses on everything “from programmagable microbes to human-machine symbiosis.” The Biological Technologies Office, like Wellcome Leap, pursues a mix of “health-focused” biotechnology programs and transhumanist endeavors.
Right before leaving the top role at DARPA, Dugan greenlighted the agency’s initial investments in mRNA vaccine techology, which led to DARPA’s investments in Pfizer and Moderna shortly thereafter. The DARPA scientist who lobbied Dugan to back the program, Dan Wattendorf, now works as the director of Innovative Technology Solutions at the Bill & Melinda Gates Foundation.
Candace Hayden was injected with the Moderna mRNA COVID-19 shot and now cannot feel anything from the waste down. Her doctor told her: “Get Used to Being Handicapped”